Sign in

    Matthew Herm

    Research Analyst at Matthew Herm LLC

    Matthew Herm is an analyst at Matthew Herm LLC, specializing in equity research and financial analysis. He has covered companies such as iBio, directly engaging with corporate earnings calls to provide detailed insights for investors. Herm has an emerging track record, having contributed qualitative analysis within his firm but without widely published performance metrics or sector rankings. While his career specifics, prior experience, and professional credentials such as FINRA registration or securities licenses are not publicly documented, Herm maintains an active presence in equity research and frequently participates in earnings events.

    Matthew Herm's questions to iBio (IBIO) leadership

    Matthew Herm's questions to iBio (IBIO) leadership • Q2 2022

    Question

    Matthew Herm of Matthew Herm LLC questioned the Board's recent resolutions to change shareholder voting requirements, asking if these changes were related to future plans for proposals like an increase in authorized shares or a reverse stock split.

    Answer

    CEO Tom Isett explained that the resolutions are a response to structural challenges and low voter turnout common among companies with large retail shareholder bases. He clarified that these issues make it difficult to achieve a quorum for annual meetings. Tom Isett confirmed the changes are intended to enable the company to conduct its business effectively and are related to putting iBio in a better position to pass proposals, such as the previously supported reverse split and share authorization increase, which failed due to insufficient vote count.

    Ask Fintool Equity Research AI